Cholongitas E, Senzolo M, Patch D, Shaw S, Hui C, Burroughs A K
Liver Transplantation and Hepatobiliary Unit, Royal Free Hospital, London, UK.
Aliment Pharmacol Ther. 2006 Aug 1;24(3):453-64. doi: 10.1111/j.1365-2036.2006.02998.x.
Cirrhotic patients admitted to intensive care units (ICU) still have poor outcomes. Some current ICU prognostic models [Acute Physiology and Chronic Health Evaluation (APACHE), Organ System Failure (OSF) and Sequential Organ Failure Assessment (SOFA)] were used to stratify cirrhotics into risk categories, but few cirrhotics were included in the original model development. Liver-specific scores [Child-Turcotte-Pugh (CTP) and model for end-stage liver disease (MELD)] could be useful in this setting.
To evaluate whether ICU prognostic models perform better compared with liver-disease specific ones in cirrhotics admitted to ICU.
We performed a structured literature review identifying clinical studies focusing on prognosis and risk factors for mortality in adult cirrhotics admitted to ICU.
We found 21 studies (five solely dealing with gastrointestinal bleeding) published during the last 20 years (54-420 patients in each). APACHE II and III, SOFA and OSF had better discrimination for correctly predicting death compared with the CTP score. The MELD score was evaluated only in one study and had good predictive accuracy [receiver operator characteristic (ROC) curve: 0.81). Organ dysfunction models (OSF, SOFA) were superior compared with APACHE II and III (ROC curve: range 0.83-0.94 vs. 0.66-0.88 respectively). Cardiovascular, liver and renal system dysfunction were more frequently independently associated with mortality.
General-ICU models had better performance in cirrhotic populations compared with CTP score; OSF and SOFA had the best predictive ability. Further prospective and validation studies are needed.
入住重症监护病房(ICU)的肝硬化患者预后仍然较差。目前一些ICU预后模型[急性生理与慢性健康状况评估(APACHE)、器官系统衰竭(OSF)和序贯器官衰竭评估(SOFA)]被用于将肝硬化患者分层为不同风险类别,但在最初的模型开发中纳入的肝硬化患者很少。肝脏特异性评分[Child-Turcotte-Pugh(CTP)和终末期肝病模型(MELD)]在这种情况下可能有用。
评估在入住ICU的肝硬化患者中,ICU预后模型与肝脏疾病特异性模型相比是否表现更好。
我们进行了一项结构化文献综述,确定了聚焦于入住ICU的成年肝硬化患者死亡率的预后和危险因素的临床研究。
我们发现了过去20年发表的21项研究(其中5项仅涉及胃肠道出血)(每项研究纳入54 - 420例患者)。与CTP评分相比,APACHE II和III、SOFA和OSF在正确预测死亡方面具有更好的辨别力。仅在一项研究中评估了MELD评分,其具有良好的预测准确性[受试者工作特征(ROC)曲线:0.81]。与APACHE II和III相比,器官功能障碍模型(OSF、SOFA)更具优势(ROC曲线分别为0.83 - 0.94和0.66 - 0.88)。心血管、肝脏和肾脏系统功能障碍更常独立与死亡率相关。
与CTP评分相比,通用ICU模型在肝硬化人群中表现更好;OSF和SOFA具有最佳预测能力。需要进一步的前瞻性和验证研究。